Vaccine Adjuvants Market Research Report and Forecast up to 2024 Vaccine Adjuvants Market

Vaccine Adjuvants Market - Global Industry
Analysis, Size, Share, Growth, Trends, and
Forecast 2016 - 2026
Vaccine Adjuvants Market: Overview
The prime objective of vaccination is to generate a strong immune response to the
administered antigen so that it can deliver strong protection against infection. The
addition of adjuvants to the vaccines is required to achieve this goal.Adjuvants are
the special compounds which have been used since decade to increase the specific
response against antigens. Adjuvant has become an important component for most
of the clinically used vaccines. Aluminum salts have been used safely in the
vaccines for almost a century and have become partially successful in promoting
the protective immunity. There has been a lot of developments done on the antigen
discovery over the past decade which has enhanced the vaccine development
process.
View Report @ http://www.transparencymarketresearch.com/vaccine-
adjuvants-market.html
Vaccine Adjuvants Market: Drivers and Restraints
The vaccine adjuvants are being driven by the factors such as high prevalence of
zoonotic and infectious diseases, growing focus on improved and long-lasting
vaccination against existing and emerging diseases. Various government bodies are
focusing on immunization programs which are also expected to drive the demand
for vaccine adjuvants. The importance of adjuvant research in vaccine development
has increased significantly due to the limited immunogenicity of new and novel
vaccine antigens. Some vaccines containing new adjuvant formulations are
gradually reaching advanced development stages, this is expected to provide a new
tool to fill earlier unmet clinical requirements. However, many adjuvants fail during
the product development due to the factors such as lack of effectiveness, stability,
unacceptable levels of tolerability, safety concerns, or manufacturability. The
increasing use of synthetic vaccines and recombinant subunit are also projected to
drive the global vaccine adjuvants market over the forecast period.
The side effects of high toxicity adjuvants, high cost for developing a new adjuvant,
strict regulatory concerns regarding the use of highly toxic adjuvants are some of
the restraints of the market. The lack of scientific awareness of the adjuvants
among some developing regions is also expected to act as a restraint on the growth
of vaccine adjuvants market over the forecast period.